Repurposing the Combination Drug of Favipiravir, Hydroxychloroquine and Oseltamivir as a Potential Inhibitor Against SARS-CoV-2: A Computational Study
Pooja Yadav, Papia Chowdhury
doi:10.21203/rs.3.rs-628277/v1
The virus SARS-CoV-2 has created a situation of global emergency all over the world from the last few months. We are witnessing a helpless situation due to COVID-19 as no vaccine or drug is effective against the disease. In the present study, we have tested the repurposing efficacy of some currently used combination drugs against COVID-19. We have tried to understand the mechanism of action of some repurposed drugs:Favipiravir (F), Hydroxychloroquine (H) and Oseltamivir (O). The ADME analysis have suggested strong inhibitory possibility of F, H, O combination towards receptor protein of 3CL pro of SARS-CoV-2 virus. The strong binding affinity, number of hydrogen bond interaction between inhibitor, receptor and lower inhibition constant computed from molecular docking validated the better complexation possibility of F+H+O:3CL pro combination. Various thermodynamical output from Molecular dynamics (MD) simulations like potential energy (Eg), temperature (T), density, pressure, SASA energy, interaction energies, Gibbs free energy (ΔGbind) etc., also favored the complexation between F+H+O and CoV-2 protease. Our in-silico results have recommended the strong candidature of combination drugs Favipiravir, Hydroxychloroquine and Oseltamivir as a potential lead inhibitor for targeting SARS-CoV-2 infections.
Supplementary Files This is a list of supplementary les associated with this preprint. Click to download.
ResearchHighlights.docx Supportingdocument.docx graphicalabstract.pdf
References
Anuj, Gaurav, Sanjeev, Mansi, Pankaj et al., Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches, Journal of Biomolecular Structure and Dynamics,
doi:10.1080/07391102.2020.1772112Apparsundaram, Ferguson, Jr, Blakely, Molecular cloning of a human, hemicholinium-3-sensitive choline transporter, Biochem. Biophys. Res. Commun
Baron, Fons, Albrecht, Viral Pathogenesis
Becke, A new inhomogeneity parameter in density-functional theory, Journal of Chemical Physics,
doi:10.1063/1.475007Benson, Daggett, A comparison of multiscale methods for the analysis of molecular dynamics simulations, The Journal of Physical Chemistry. B,
doi:10.1021/jp302103t22494262Berendsen, Van Der Spoel, Van Drunen, GROMACS: A message passing parallel molecular dynamics implementation, Computer Physics Communications,
doi:10.1016/0010-4655(95)00042-EBurley, Berman, Bhikadiya, Bi, Chen et al., RCSB Protein Data Bank: Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy, Nucleic Acids Research,
doi:10.1093/nar/gky1004Cao, Deng, Dai, Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel medicine and infectious disease,
doi:10.1016/j.tmaid.2020.101647Chan, Yao, Yeung, Deng, Bao et al., Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset, The Journal of infectious diseases
Chang, Lo, Wang, Hou, Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein, Drug Discovery Today
Choudhary, Shaikh, Tul-Wahab, Ur-Rahman, In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation, Plos one
Chowdhury, Pathak, Neuroprotective Immunity by Essential Nutrient "Choline" for the Prevention of SARS CoV2 Infections: An In Silico Study by Molecular Dynamics Approach, Chemical Physics Letters,
doi:10.1016/j.cplett.2020.138057Chowdhuryp, In silico investigation of phytoconstituents from indian medicinal herb 'Tinospora Cordifolia (Giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach, J. Biomol. Struct. Dyn,
doi:10.1080/07391102.2020.1803968Costanzo, Giglio, SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus, Current Medicinal Chemistry,
doi:10.2174/0929867327666200416131117Daina, Michielin, Zoete, Swiss ADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep,
doi:10.1038/srep42717Dennington, Keith, Millam, Gauss View, Version 4.1
Dey, Saini, Dhembla, Bhatt, Rajesh et al., Suramin, Penciclovir and Anidulafungin bind nsp12, which governs the RNA-dependent-RNA polymerase activity of SARS-CoV-2, with higher interaction energy than Remdesivir, indicating potential in the treatment of Covid-19 infection
Dharmendra, Molecular insights into the interaction of RONS and Thieno [3,2-c]pyran analogs with SIRT6/COX-2: a molecular dynamics study, Scientific Reports,
doi:10.1038/s41598-018-22972-9Doi, Ikeda, Hayase, Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series, Crit Care,
doi:10.1186/s13054-020-03078-zDong, Li, Teng, Yin, Cao, Syntheses and neuroprotective effects evolution of oxymatrine derivatives as anti-Alzheimer's disease agents, Chemical Biology & Drug Design
Dyall, Coleman, Hart, Venkataramant, Holbrook et al., Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection, Antimicrobial
Elfiky, Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study, Life Sciences,
doi:10.1016/j.lfs.2020.117592Falzarano, Wit, Rasmussen, Feldmann, Okumura et al., Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques, Nature medicine
Frecer, Miertus, Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease, RSC Advances
Fried, Shiffman, Reddy, Smith, Marinos et al., Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection, New England Journal of Medicine
Frisch, Gaussian 09
Furukawa, Brooks, Sobel, Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic, Emerg. Infect. Dis,
doi:10.3201/eid2607.201595Furuta, Takahashi, Fukuda, Kuno, Kamiyama et al., In vitro and in vivo activities of anti-influenza virus compound T-705, Antimicrob. Agents Chemother
Gautret, Lagier, Parola, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents,
doi:10.1016/j.ijantimicag.2020.105949Ghinai, First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA, The Lancet,
doi:10.1016/S0140-6736(20)30607-3Gorden, Gwendolynmj, Bouhaddou, A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing,
doi:10.1101/2020.03.22.002386Grant, Doxycycline prophylaxis for bacterial sexually transmitted infections, Clinical Infectious Diseases
Grein, Ohmagari, Shin, Diaz, Asperges et al., Compassionate use of remdesivir for patients with severe Covid-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2007016Guan, Ni, -Y, Hu, Liang et al., Clinical characteristics of Coronavirus disease 2019 in China, The New England Journal of Medicine,
doi:10.1056/NEJMoa2002032Gunsteren, Billeter, Eising, Hünenberger, Krüger et al., Biomolecular simulation: The GROMOS96 manual and user guide
Gupta, Singh, Kushwaha, Prajapati, Shuaib et al., Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies, Journal of Biomolecular Structure and Dynamics,
doi:10.1080/07391102.2020.1776157Harrison, Coronavirus puts drug repurposing on the fast track, Nature biotechnology
Hart, Dyall, Postnikova, Zhou, Kindrachuk et al., Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays, The Journal of general virology,
doi:10.1099/vir.0.061911-0He, Xiao, Yu, Song, Zhang et al., 2-(3-Hydroxybenzyl) benzo [d] isothiazol-3 (2H)-one Mannich base derivatives as potential multifunctional anti-Alzheimer's agents, Medicinal Chemistry Research
Heidary, Gharebaghi, Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen, The Journal of Antibiotics
Hoffmann, Schroeders, Kleine-Weber, Müller, Drosten et al., Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19, Antimicrobial Agents and Chemotherapy
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Hung, Lung, Tso, Liur, Chung et al., Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label,randomised, phase 2 trial, The Lancet
Hurt, Holien, Parker, Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal. Pandemic and Highly Pathogenic Influenza Viruses, Drugs,
doi:10.2165/11531450-000000000-00000Jiang, Deng, Zhang, Cai, Cheungcw et al., Review of the clinical characteristics of coronavirus disease 2019 (COVID-19), Journal of General Internal Medicine,
doi:10.1007/s11606-020-05762-wKapoor, Saigal, Elongavan, Action and resistance mechanisms of antibiotics: A guide for clinicians, J Anaesthesiol Clin Pharmacol,
doi:10.4103/joacp.JOACP_349_15Kaur, Charan, Dutta, Sharma, Bhardwaj et al., Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infection and drug resistance
Keil, Ali, The avian flu: some lessons learned from the 2003 SARS outbreak in Toronto, Area
Kelleni, Nitazoxanide/Azithromycin combination for COVID-19: A suggested new protocol for COVID-19 early management
Kollman, Massova, Reyes, Kuhn, Huo et al., Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models, Acc. Chem. Res,
doi:10.1021/ar000033jLi, Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster. Xuzhou, China, Emerg. Infect. Dis,
doi:10.3201/eid2607.200718Martorana, Gentile, Lauria, In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection, Viruses
Mcdowell, Nada, Sponer, Walter, Molecular Dynamics Simulations of RNA: An In Silico Single Molecule Approach, Biopolymers,
doi:10.1002/bip.20620Micco, Musella, Scala, Sala, Campiglia et al., In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate, Frontiers in Chemistry
Morris, Huey, Lindstrom, Sannermf, Belew et al., AutoDock4 and Auto Dock Tools4: Automated docking with selective receptor flexibility, Journal of Computational Chemistry,
doi:10.1002/jcc.21256Muradrasoli, Balint, Wahlgren, Waldenstrom, Belak et al., Prevalence and Phylogeny of Coronaviruses in Wild Birds from the Bering Strait Area (Beringia), PLoS ONE,
doi:10.1371/journal.pone.0013640Ortega, Serrano, Pujolfh, Rangel, Role of changes in SARS-COV-2 spike protein in the interaction with the human ACE2 Receptor: an in silico analysis, EXCLI Journal,
doi:10.17179/excli2020-1167Pooja, Chowdhury, Influence of size and shape on optical and electronic properties of CdTe quantum dots in aqueous environment
Priyadarsini, Pandas, Singh, Beheraa, Biswal et al., In silico structural delineation of nucleocapsid protein of SARS-CoV-2, Journal of Entomology and Zoology Studies
Rainsford, Parke, Clifford-Rashotte, Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases, Inflammopharmacol,
doi:10.1007/s10787-015-0239-yRana, Chowdhury, Perturbation of hydrogen bonding in hydrated pyrrole-2-carboxaldehyde complexes, Journal of molecular modeling
Rashmi, Rajendra, Andrew, g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model,
doi:10.1021/ci500020mRota, Oberste, Monroe, Nix, Campagnoli et al., Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science,
doi:10.1126/science.1085952Rothe, Schunk, Sothmann, Bretzel, Froeschl et al., Transmission of 2019-nCoV infection from an asymptomatic contact in Germany, New England, Journal of Medicine,
doi:10.1056/NEJMc2001468Selvaraj, Panwar, Dinesh, Boura, Singh et al., Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease, Front. Chem,
doi:10.3389/fchemSepaynayim, Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study, Journal of molecular structure,
doi:10.1016/j.molstruc.2020.129433Shalhoub, Farahat, Simhairi, Shamma, Siddiqi et al., IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study, Journal of Antimicrobial Chemotherapy
Shannon, Selisko, Le, Huchting, Touret et al., Favipiravir strikes the SARS-CoV-2 at its Achilles heel. the RNA polymerase
Su, Wong, Shi, Liu, Lai et al., Epidemiology, genetic recombination, and pathogenesis of coronaviruses, Trends Microbiol,
doi:10.1016/j.tim.2016.03.003Suryapad, Chi, Lees, Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective, J. Tradit. Complement. Med
Ter Meulen, Van Den, Brink, Poon, Marissen et al., Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants, PLoS Med
Thorlund, Dron, Park, Hsu, Forrest et al., A real-time dashboard of clinical trials for COVID-19, The Lancet Digital Health
Trott, Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem,
doi:10.1002/jcc.21334Veber, Johnson, Cheng, Smith, Ward et al., Molecular properties that influence the oral bioavailability of drug candidates, J. Med. Chem
Velavan, Meyercg, The COVID-19 epidemic. Tropical Medicine & International Health, TM & IH,
doi:10.1111/tmi.13383Wang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA,
doi:10.1001/jama.2020.1585Woo, Lau, Chu, Chan, Tsoi et al., Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia, Journal of Virology,
doi:10.1128/JVI.79.2.884-895.2005Yang, Use of herbal drugs to treat COVID-19 should be with caution, The Lancet
Yin, Mao, Luan, Shen, Shen et al., Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by Remdesivir, Science
Zhou, Huang, Synthesis, anti-malaria and anti-bacterial activities of marine alkaloids, Chemical Biology & Drug Design
{ 'institution': [{'name': 'Research Square'}],
'indexed': {'date-parts': [[2022, 4, 2]], 'date-time': '2022-04-02T18:29:46Z', 'timestamp': 1648924186483},
'posted': {'date-parts': [[2021, 6, 21]]},
'group-title': 'In Review',
'reference-count': 0,
'publisher': 'Research Square Platform LLC',
'license': [ { 'start': { 'date-parts': [[2021, 6, 21]],
'date-time': '2021-06-21T00:00:00Z',
'timestamp': 1624233600000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'accepted': {'date-parts': [[2021, 6, 16]]},
'abstract': '<jats:title>Abstract</jats:title>\n'
' <jats:p>The virus SARS-CoV-2 has created a situation of global emergency all over the '
'world from the last few months. We are witnessing a helpless situation due to COVID-19 as no '
'vaccine or drug is effective against the disease. In the present study, we have tested the '
'repurposing efficacy of some currently used combination drugs against COVID-19. We have tried '
'to understand the mechanism of action of some repurposed drugs:Favipiravir (F), '
'Hydroxychloroquine (H) and Oseltamivir (O). The ADME analysis have suggested strong '
'inhibitory possibility of F, H, O combination towards receptor protein of '
'3CL<jats:sup>pro</jats:sup> of SARS-CoV-2 virus. The strong binding affinity, number of '
'hydrogen bond interaction between inhibitor, receptor and lower inhibition constant computed '
'from molecular docking validated the better complexation possibility of F\u2009+\u2009H\u2009'
'+\u2009O:3CL<jats:sup>pro</jats:sup>combination. Various thermodynamical output from '
'Molecular dynamics (MD) simulations like potential energy (E<jats:sub>g</jats:sub>), '
'temperature (T), density, pressure, SASA energy, interaction energies, Gibbs free energy '
'(ΔG<jats:sub>bind</jats:sub>) etc., also favored the complexation between F\u2009+\u2009'
'H\u2009+\u2009O and CoV-2 protease. Our in-silico results have recommended the strong '
'candidature of combination drugs Favipiravir, Hydroxychloroquine and Oseltamivir as a '
'potential lead inhibitor for targeting SARS-CoV-2 infections.</jats:p>',
'DOI': '10.21203/rs.3.rs-628277/v1',
'type': 'posted-content',
'created': {'date-parts': [[2021, 6, 21]], 'date-time': '2021-06-21T15:19:25Z', 'timestamp': 1624288765000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Repurposing the Combination Drug of Favipiravir, Hydroxychloroquine and Oseltamivir as a '
'Potential Inhibitor Against SARS-CoV-2: A Computational Study',
'prefix': '10.21203',
'author': [ { 'given': 'Pooja',
'family': 'Yadav',
'sequence': 'first',
'affiliation': [{'name': 'Jaypee Institute of Information Technology'}]},
{ 'ORCID': 'http://orcid.org/0000-0001-9702-2553',
'authenticated-orcid': False,
'given': 'PAPIA',
'family': 'CHOWDHURY',
'sequence': 'additional',
'affiliation': [{'name': 'Jaypee Institute of Information Technology'}]}],
'member': '8761',
'container-title': [],
'original-title': [],
'link': [ { 'URL': 'https://www.researchsquare.com/article/rs-628277/v1',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.researchsquare.com/article/rs-628277/v1.html',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 6, 21]],
'date-time': '2021-06-21T15:19:27Z',
'timestamp': 1624288767000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.researchsquare.com/article/rs-628277/v1'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 6, 21]]},
'references-count': 0,
'URL': 'http://dx.doi.org/10.21203/rs.3.rs-628277/v1',
'relation': {},
'subject': [],
'published': {'date-parts': [[2021, 6, 21]]},
'subtype': 'preprint'}
